Company Overview of Capricor Therapeutics, Inc.
Earl M. Collier Jr., J.D., Esq.
Director and Chairman of Nominating & Corporate Governance Committee, Capricor Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 9 Board Members in 9 different organizations across 16 different industries.|
See Board Relationships
8840 Wilshire BoulevardPhone: 310-358-3200
Beverly Hills, California 90211
Board Members Memberships
Director and Chairman of Nominating & Corporate Governance Committee
Independent Director, Chairman of Governance & Nominating Committee and Member of Compensation Committee
University of Virginia School of Law
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Robin C. Stracey||Chief Executive Officer, President and Director|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Mike Tomas||Chief Executive Officer, President, Chief Financial Officer and Director|
U.S. Stem Cell, Inc.
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|Christian Homsy M.D., MBA||Chief Executive Officer and Executive Director|
|$579.0K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.